Product
IVIEW-1201
Aliases
Treatment Arm
3 clinical trials
3 indications
Indication
ConjunctivitisIndication
Bacterial ConjunctivitisIndication
Fungal KeratitisClinical trial
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral ConjunctivitisStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial ConjunctivitisStatus: Completed, Estimated PCD: 2023-09-13
Clinical trial
A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal KeratitisStatus: Not yet recruiting, Estimated PCD: 2026-12-01